|
|
||||||||

,*
* Research Institute of McGill University Health Center, Center for the Study of Host Resistance, Departments of Medicine, Microbiology, and Immunology, McGill University, Montréal, Québec, Canada; and
Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Pavillon Centre Hospitalier de lUniversité Laval, and Département de Biologie Médicale, Faculté de Médecine, Université Laval, Ste-Foy, Québec, Canada
| Abstract |
|---|
|
|
|---|
) chemokine mRNA expression. We found that both Plasmodium falciparum HZ and synthetic HZ increase mRNA levels of various chemokine transcripts (MIP-1
/CCL3, MIP-1
/CCL4, MIP-2/CXCL2, and MCP-1/CCL2) in murine B10R M
. The cellular response to HZ involved ERK1/2 phosphorylation, NF-
B activation, reactive oxygen species (ROS) generation, and ROS-dependent protein-tyrosine phosphatase down-regulation. Selective inhibition of either I
B
or the ERK1/2 pathway abolished both NF-
B activation and chemokine up-regulation. Similarly, blockage of HZ-inducible M
ROS with superoxide dismutase suppressed chemokine induction, strongly reduced NF-
B activation, and restored HZ-mediated M
protein-tyrosine phosphatase inactivation. In contrast, superoxide dismutase had no effect on EKR1/2 phosphorylation by HZ. Collectively, these data indicate that HZ triggers ROS-dependent and -independent signals, leading to increased chemokine mRNA expression in M
. Overall, our findings may help to better understand the molecular mechanisms through which parasite components, such as HZ, modulate the immune response during malaria infection. | Introduction |
|---|
|
|
|---|
/CCL3 and IL-8/CXCL8 were detected during acute infection (4). In placental malaria, increased MIP-1
, IL-8, and MCP-1/CCL2 mRNA expression was associated with placental monocyte recruitment (5), a risk factor for low birth weight (6). In addition, experimental models of cerebral malaria have underlined the importance of the neutrophil (N
) population in the development of this pathology (7) and have shown the ability of both N
and macrophages (M
) to express elevated chemokine mRNA levels (8).
In an attempt to identify the parasite components that are responsible for the activation of the host immune response during malaria, we (9, 10) and others (11, 12, 13) have focused on evaluating the proinflammatory properties of hemozoin (HZ) or malarial pigment. HZ crystals result from aggregated heme, which is produced during hemoglobin digestion inside the host RBC (14). This pigment is released after schizogeny, along with merozoites, as the RBC bursts and is phagocytosed by circulating monocytes, N
, and resident M
(reviewed by Arese and Schwarzer (15)). Both Pf HZ and synthetic HZ (sHZ), which is structurally identical with the native pigment (16), induced the release of MIP-1
and MIP-1
/CCL4 as well as of TNF-
and IL-1
in murine M
and human PBMC (11, 12). These observations were also supported by our in vivo data indicating that sHZ leads to liver chemokine and cytokine mRNA up-regulation in i.v. injected mice and to significant leukocyte recruitment and proinflammatory mediator release in the air pouch lumen of mice inoculated intradermally (10). In line with these findings, Biswas and colleagues (13) reported the presence of Abs against Pf HZ among complicated malaria patients, which had inhibitory effects on HZ-dependent monocyte cytokine production. Although these studies strongly suggest that HZ is likely to play a key role in proinflammatory mediator overproduction, the mechanism by which such regulation occurs remains unexplored. In the present study we demonstrate that both Pf HZ and sHZ increase mRNA levels of various chemokines (MIP-1
, MIP-1
, MIP-2, and MCP-1) in murine M
through a mechanism that involves activation of oxidative stress-dependent and -independent pathways. A better understanding of the transductional signals through which HZ modulates the host immune response might be helpful in defining specific therapeutic targets to tame proinflammatory mediator overproduction during malaria infection.
| Materials and Methods |
|---|
|
|
|---|
Hemin chloride, polymyxin B (Poly B) sulfate, LPS (Escherichia coli, serotype 0111:B4), 3% H2O2 (v/v), and superoxide dismutase (SOD) were purchased from Sigma-Aldrich. Isotopes [
-32P]dUTP (3000 Ci/mmol) and [
-32P]dATP (3000 Ci/mmol) were obtained from PerkinElmer. BAY 11-7082 was purchased from BIOMOL. Apigenin and PD 98059 were obtained from Calbiochem.
Cell and culture conditions
The murine M
cell line B10R, derived from the bone marrow of B10A.Bcgr (B10R) mice (17), was provided by Dr. D. Radzioch (McGill University, Montréal, Canada). Cells were maintained in DMEM (Invitrogen Life Technologies) supplemented with 10% heat-inactivated FBS (HyClone) plus 100 µg/ml streptomycin and 2 mM L-glutamine at 37°C and 5% CO2.
Cell viability assays
(3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenil)-2-(4-sulfophenyl)-2H-tetrazolium (inner salt) assays for cell viability were performed and indicated no cytotoxic or cytostatic effect from the various specific inhibitors at the concentrations used (data not shown). Briefly, B10R M
were seeded in 96-well plates (3 x 104 cells/well) and were stimulated for 3 h with increasing concentrations of the various inhibitors (100 µl). Then, cells were incubated with 10 µl of a 20/1 solution of 2 mg/ml (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenil)-2-(4-sulfophenyl)-2H-tetrazolium (inner salt; Promega) and 3 mM phenazine methosulfate (Sigma-Aldrich) for 1 h, and OD was read at 492 nm.
-Hematin (sHZ) preparation
-Hematin was synthesized as previously described (9). Briefly, 45 mg of hemin chloride (Sigma-Aldrich) was solubilized in 4.5 ml of 1 N NaOH and neutralized with 450 µl of 1 N HCl. Then, 10.2 ml of 1 M sodium acetate, pH 4.8, was added, and the suspension was stirred with a magnet for 23 h at 60°C. After addition of 1/100 volume of 10% SDS and 14,000 x g centrifugation for 15 min, the pellet was sonicated at the lowest setting in 100 mM sodium bicarbonate (pH 9.0)/0.5% SDS and again centrifuged. The pellet was then washed three or four times in 2% SDS and then in water to wash out the SDS. The pigment was dried at 37°C overnight, resuspended in PBS-endotoxin free (Life Technologies) at a final concentration of 2.5 mg/ml, and kept at 20°C. Pf HZ was extracted as described previously (9) and was provided by Dr. D. C. Gowda (Pennsylvania State University College of Medicine, Hershey, PA). To assess the level of endotoxins in the HZ preparations, the Limulus amebocyte lysate test (E-toxate kit; Sigma-Aldrich) was performed, and no endotoxin contamination was detected.
Heme quantitation
The total heme content was determined, as described by Sullivan et al. (18), by adding 20 mM NaOH/2% SDS to the HZ preparations, incubating the suspension at room temperature for 2 h, and then reading the OD at 400 nm (DGB UV/visible spectrophotometer; Beckman Coulter). Twenty-five micrograms of sHZ equals 26 nmol of heme content, and 25 µg of Pf HZ equals 29 nmol of heme content. It should be noted that the concentrations of HZ used to stimulate M
(2575 µg/ml) were chosen based on reported estimates of the HZ concentrations encountered during malaria infection (12, 19, 20) as well as on previous studies in which these amounts of HZ were shown to be effective both in vitro and in vivo (12, 21). Briefly, by reference to standard hematological measurements and assuming that 1) a 70-kg adult has a 1% synchronized Pf parasitemia (a relatively mild parasite load), 2) 50% of the hemoglobin in an infected cell is degraded, and 3) all heme in the degraded hemoglobin is converted into HZ, it has been estimated that as much as 200 µmol of HZ (
3 µmol/kg) is released into the circulation of a Pf-infected human patient at schizogeny (12). In addition, it was calculated that 106 Pf trophozoite-infected RBC contain between 339 and 652 ng of HZ (equal to 0.51.0 nmol of heme content) (19, 20). According to these data, the concentrations of HZ used in the current study (
2629 nmol/ml heme content) could be easily released by a patient with a mild parasitemia load.
RNase protection assay (RPA)
mRNA expression studies were performed using an RPA kit (RiboQuant; BD Pharmingen), as we described previously (22). Total RNA was isolated from stimulated cells with TRIzol reagent (Invitrogen Life Technologies) according to the manufacturers protocol. One of the multiprobe templates was labeled with [
-32P]dUTP using T7 RNA polymerase. Then, 3 x 105 cpm of labeled probe was allowed to hybridize with 10 µg of total RNA for 16 h at 56°C. mRNA probe hybrids were treated with RNase A and phenol-chloroform-extracted. Protected hybrids were resolved on a 5% denaturing polyacrylamide sequencing gel and exposed to radiographic film overnight at 80°C. Laser densitometry was performed using an
Imager 2000 digital imaging and analysis system (
Innotech). The multiprobe templates (BD Pharmingen) used in this study were mCK-5, for the murine chemokines lymphotactin, RANTES, eotaxin, MIP-1
, MIP-1
, MIP-2, inducing protein-10, MCP-1, and TCA-3, and a custom template for murine cytokines IL-4, IL-12p40, IL-10, IL-1
, IL-1
, IL-2, IL-6, and IFN-
. The template sets included housekeeping genes ml-32 and/or GAPDH.
EMSA
Cell stimulation was terminated by the addition of ice-cold PBS, nuclear extracts were prepared according to the microscale protocol, and EMSA was performed using 6 µg of nuclear proteins, as we described previously (22). Briefly, nuclear extracts were incubated for 20 min at room temperature in 1.0 µl of binding buffer (100 mM HEPES (pH 7.9), 40% glycerol, 10% Ficoll, 250 mM KCl, 10 mM DTT, 5 mM EDTA, and 250 mM NaCl), 2 µg of poly(dI-dC) and 10 µg of nuclease-free BSA (fraction V; Sigma-Aldrich) containing 1.0 ng of [
-32P]dATP radiolabeled dsDNA oligonucleotide. This mixture was incubated for 20 min at room temperature, and the reaction was stopped using 5 µl of 0.2 M EDTA. DNA-protein complexes were resolved from free-labeled DNA by electrophoresis in native 4% (w/v) polyacrylamide gels containing 50 mM Tris-HCl (pH 8.5), 200 mM glycine, and 1 mM EDTA. The gels were subsequently dried and autoradiographed. The dsDNA oligonucleotide containing a consensus binding site for NF-
B/c-Rel homodimeric and heterodimeric complexes (5'-AGTTGAGGGGACTTTCCCAGGC-3') was obtained from Santa Cruz Biotechnology. The oligonucleotides containing NF-
B-binding sites of the murine chemokine promoters were synthesized in our laboratory as follows: NF-
B/MIP-2, 5'-GAGCTCAGGGAATTTCCCTGGTCC-3' (23); and NF-
B/MCP-1, 5'-AAGGGTCTGGGAACTTCCAATACTGC-3' (24). The nonspecific probe Oct-2A (5'-GGAGTATCCAGCTCCGTAGCATGCAAATCCTCTGG 3'), which was used to confirm the specificity of the DNA/nuclear protein reaction, was also synthesized in our laboratory. Cold competitor assays were conducted by adding a 100-fold molar excess of homologous unlabeled oligonucleotides of the various labeled dsDNA probes. Supershift assays were performed by preincubation of nuclear extracts with 2 µg of polyclonal Abs against p65 (Rel A) or p50 (Santa Cruz Biotechnology) in the presence of all components of the binding reaction described above for 1 h at 4°C.
Western blotting
Cells were collected after stimulation, lysed in cold buffer containing 20 mM Tris-HCl (pH 8.0), 0.14 M NaCl, 10% glycerol (v/v), 1% Igepal (v/v), 25 µM nitrophenyl guanidinobenzoate, 10 µM sodium fluoride, 1 mM sodium orthovanadate, 25 µg/ml leupeptin, and aprotinin. The lysates (20 µg/lane) were subjected to SDS-PAGE, and the separated proteins were transferred onto a polyvinylidene difluoride membrane (Millipore). After a 1-h blocking period in TBST containing 5% milk, the membranes were incubated overnight in TBST/5% BSA at 4°C with one of the following rabbit polyclonal Abs (New England Biolabs): phospho-ERK1/2 (Thr202/Tyr204), ERK1/2, phospho-MEK1/2 (Ser217/221), MEK1/2, phospho-I
B
(Ser32), and I
B
. Proteins were then detected with an anti-rabbit, HRP-conjugated, goat Ab (Affini-Pure; Jackson ImmunoResearch Laboratories) and subsequent visualization by ECL (ECL Western blotting detection system; Amersham Biosciences).
Phosphatase activity
After stimulation, M
were washed in PBS and lysed in a buffer containing 50 mM Tris-HCl (pH 7.0), 0.1 mM EDTA, 0.1 mM EGTA, 0.1% 2-ME (v/v), 1% Igepal (v/v), 25 µg/ml aprotinin, and 25 µg/ml leupeptin. Cellular protein-tyrosine phosphatase (PTP) activity was determined by evaluating the capacity of cell lysates to hydrolyze para-nitrophenyl phosphate (pNPP; Roche), as we previously described (25). Briefly, 20 µg of total proteins were incubated with 180 µl of a reaction mixture containing 50 mM HEPES (pH 7.5), 0.1% 2-ME (v/v), and 10 mM pNPP. After a 10- to 60-min incubation at 37°C, PTP activity was monitored, reading the OD at 405 nm (DGB UV/visible spectrophotometer; Beckman Coulter).
Oxidative stress generation
To monitor reactive oxygen species (ROS) generation, M
were seeded in 96-well plates (3 x 104 cells/well), and after two washes with PBS, they were incubated for 30 min with H2DCFDA, 2',7'-dichlorofluorescein diacetate (Calbiochem), a commonly used fluorogenic probe, diluted to a final concentration of 100 µM. Cell washing was followed by a 1-h exposure to either H2O2 or sHZ with or without SOD, and fluorescence was read at 485/530 nm using an LS50 luminescence spectrometer (PerkinElmer).
Statistical analysis
Statistically significant differences between groups were determined by ANOVA module of StatView Plus SE software (Abacus Concepts) and Fishers least significant difference test. A value of p < 0.05 was considered statistically significant. All data are presented as the mean ± SEM.
| Results |
|---|
|
|
|---|
chemokine mRNA expression
M
have been identified as one of the main sources of proinflammatory mediators in response to Pf infection (2). Thus, we initially established whether HZ induced chemokine mRNA expression in the murine M
cell line B10R. As depicted in Fig. 1A, when cells were stimulated for 2 h with 1075 µg/ml of either Pf HZ or its synthetic form, sHZ, a concentration-dependent increase in various chemokine transcripts was detected. Maximal values over the negative control were obtained for MIP-1
(3- and 4-fold), MIP-1
(2- and 3-fold), MIP-2 (140- and 170-fold), and MCP-1 (3- and 4-fold) when 75 µg/ml Pf HZ or sHZ was added, respectively. In addition, time-course experiments performed with an intermediate concentration of sHZ (25 µg/ml) revealed that chemokine induction occurred very rapidly (0.51 h poststimulation), peaked after 2 h, and transiently decreased over an 8-h period (Fig. 1B). Subsequent experiments presented in this section are those after cell stimulation with sHZ; however, all of them were performed in parallel with Pf HZ, and the results were the same as those obtained with sHZ.
|
To demonstrate that chemokine expression in response to sHZ was not due to the presence of LPS, cells were incubated for 2 h in culture medium (DMEM/10% FBS) containing either LPS (100 ng/ml) or sHZ (25 µg/ml) and treated, or not, with 510 µg/ml Poly B for 30 min before cell stimulation. Because Poly B binds to LPS and blocks its activity (26), this compound has the ability to inhibit LPS-inducible M
activation. As shown in Fig. 2A, Poly B did not exert any inhibitory effect on sHZ-dependent chemokine modulation; however, this compound dramatically reduced the chemokine increase in response to LPS, reaching 100% of inhibition in the presence of 10 µg/ml Poly B. These data are in line with those of our previous study showing that the synergistic effect of sHZ on IFN-
-mediated NO production was not reduced in the presence of Poly B and was not affected in TLR4-deleted M
-derived from LPS-unresponsive mice. In contrast, the ability of LPS to induce NO synthesis was suppressed upon Poly B pretreatment and was abolished in TLR4-deleted M
(9). In addition, we found that although LPS, at very low concentrations (0.1 and 1 ng/ml), led to the up-regulation of various proinflammatory cytokine transcripts (IL-12, IL-1
, IL-1
, and IL-6), sHZ was unable to do so even when added at 25 µg/ml (Fig. 2B). This set of experiments indicates the absence of LPS in the sHZ preparations and suggests that the two agonists exert different biological effects on M
.
|
The role of ERK1/2 MAPK on chemokine induction is well documented (22, 27). Therefore, we tested the ability of sHZ to activate this signaling cascade. A transient phosphorylation of the immediate ERK1/2 upstream activator MEK1/2 (Fig. 3A) and of ERK1/2 (Fig. 3B) occurred after cell exposure to sHZ (25 µg/ml). Both MEK1/2 and ERK1/2 phosphorylation were detected at 30 min poststimulation and remained sustained for up to 2 h. Whereas MEK1/2 phosphorylation declined thereafter, that of ERK1/2 was still detectable after 4 h. To investigate the involvement of the ERK1/2 pathway in sHZ-mediated chemokine up-regulation, cells were incubated for 1 h with increasing concentrations of specific inhibitors directed against MEK1/2 (PD 98059) and ERK1/2 (apigenin) before sHZ stimulation (2 h). As shown in Fig. 4A, 5 µM PD 98059 inhibited the expression of all four chemokines. In correlation with these observations, cell exposure to 20 µM apigenin resulted in a marked reduction of their chemokine transcripts (Fig. 4B;
45% for MIP-1
,
50% for MIP-1
,
60% for MIP-2, and
40% MCP-1), whereas maximal inhibitor concentrations (40 µM) completely abrogated chemokine expression. These results indicate that ERK1/2-dependent signals are necessary for M
chemokine modulation in response to the malarial pigment.
|
|
B on sHZ-dependent chemokine induction
NF-
B proteins control the expression of multiple genes involved in inflammatory processes such as those encoding chemokines (28). Of interest, NF-
B binding sites have been found in the promoter regions of several murine chemokine genes, including those of MIP-2 (23) and MCP-1 (24). Based on these observations, we sought to establish whether this NF was activated in M
by sHZ. As shown in Fig. 5A, NF-
B nuclear translocation was maximal at 1 h poststimulation and then decreased over a 4-h period. To define the nature of the sHZ-induced NF-
B complex, supershift assays were performed using Abs directed at p50 and p65, two ubiquitous members of the NF-
B family. As illustrated in Fig. 5B, the complex binding was diminished and partially supershifted in the presence of an anti-p50 Ab and was almost completely abrogated by an anti-p65 Ab. These data indicated that sHZ activates DNA binding of both p50 and p65 NF-
B subunits in M
. To address the question of whether sHZ not only led to NF-
B nuclear translocation but also to its binding to one or more chemokine genes, nuclear extracts from sHZ-stimulated cells were incubated with oligonucleotides containing specific sequences of the NF-
B-binding sites present in the murine MIP-2 and MCP-1 promoters. We observed that after 1 h, sHZ led to maximal NF-
B binding to both sites. Whereas NF-
B binding to the MIP-2 sequence was sustained for up to 4 h, NF-
B binding to the MCP-1 promoter was transient, but still detectable at 4 h poststimulation (Fig. 5C). Given that specific blockage of the ERK1/2 pathway abolished chemokine expression, we next determined its involvement in sHZ-inducible I
B
phosphorylation and subsequent NF-
B nuclear translocation. As illustrated in Fig. 6A, sHZ led to a rapid phosphorylation of I
B
(15 min poststimulation). This intracellular event appeared to be under the control of MEK1/2-ERK1/2-dependent signals, because specific inhibitors directed against these MAPKs abrogated the effect of sHZ on I
B
. Similarly, cell exposure to either apigenin or PD 98059 caused a concentration-dependent diminution of NF-
B nuclear translocation (Fig. 6B). These data prompted us to further evaluate the role of NF-
B in chemokine modulation. As a control experiment, M
were incubated for 1 h with BAY 11-7082 (1 or 5 µM), an inhibitor of I
B
phosphorylation (29), before sHZ stimulation, and NF-
B nuclear translocation was monitored by EMSA (Fig. 6C). As expected, cells incubated with BAY 11-7082 showed a concentration-dependent reduction in the binding of the NF-
B complex. We were thus interested in examining the effect of this inhibitor on chemokine induction. To this end, after cell stimulation, as described in the previous experiment, total RNA was extracted and subjected to RPA analysis. As illustrated in Fig. 6D, M
exposure to 5 µM BAY 11-7082 abrogated the expression of all four transcripts. These data suggest that chemokine modulation in response to sHZ involves ERK1/2-dependent NF-
B activation.
|
|
M
from Pf-infected mice were shown to release oxygen metabolites (30) and in vitro oxidative killing of Pf was described in peritoneal M
(31). Similarly, in response to Pf HZ (32) or sHZ (33), peritoneal M
produced ROS. Therefore, we assessed whether sHZ generated ROS in B10R M
(Fig. 7A). When cells were stimulated with 1050 µg/ml sHZ, a concentration-dependent induction of ROS was detected, which was statistically significant compared with that in untreated M
(OD values) and was equivalent to 30% of the oxidative stress generated upon administration of exogenous H2O2 (500 µM). In addition, we found that most of the ROS produced by sHZ-stimulated M
corresponded to superoxide anion (O ![]()
![]()
B activation, and chemokine modulation were due to ROS generation. Whereas SOD pretreatment (300 U/ml) did not affect ERK1/2 phosphorylation (data not shown), NF-
B nuclear translocation in response to sHZ was strongly reduced in the presence of this enzyme (Fig. 7C). Importantly, cell incubation with 300 U/ml SOD abrogated the expression of all chemokine transcripts (Fig. 7D). This set of experiments demonstrated that the malarial pigment leads to a mild oxidative stress in M
, which seems to be in part responsible for NF-
B activation and is required for sHZ-inducible chemokine mRNA up-regulation.
|
PTP inactivation in response to sHZ is ROS dependent
Intracellular signaling is regulated by the equilibrium between protein-tyrosine kinase (PTK) and PTP activity. Knowing that PTP inactivation occurs in response to ROS, including O ![]()
signal transduction activation. To this end, time-course experiments were conducted in the presence of sHZ (25 µg/ml) from 5 min to 4 h, and M
PTP activity was monitored. As shown in Fig. 8A, sHZ rapidly down-regulated M
PTP activity, leading to a significant diminution (
40% reduction compared with basal activity) after a 30-min treatment and a more dramatic decrease (
55%) after 2 h. Next, we evaluated whether the effect of sHZ on M
PTP activity was due to its ability to induce ROS. When cells were treated with 75300 U/ml SOD before sHZ stimulation, M
PTP activity was restored in a concentration-dependent manner, reaching up to 93% of basal PTP activity in the presence of 300 U/ml SOD (Fig. 8B). Collectively, these data indicate that M
PTP inactivation in response to sHZ is an early event that seems to be dependent on oxidative stress.
|
| Discussion |
|---|
|
|
|---|
have been proposed as one of the main sources of proinflammatory mediators (2); therefore, it is of paramount importance to identify the parasite components participating in chemokine induction and to define the underlying regulatory mechanisms. In this regard, Sherry et al. (12) reported that both Pf HZ and sHZ lead to the release of chemokines MIP-1
and MIP-1
in murine M
and human PBMC. More recently, we demonstrated that sHZ also induces chemokine transcription and secretion in vivo (10). Confirming and extending these previous findings, we show that either Pf HZ or sHZ increases mRNA levels of MIP-1
, MIP-1
, MIP-2, and MCP-1 in B10R murine M
through a mechanism that is oxidative stress and ERK1/2 dependent and involves PTP down-regulation and NF-
B activation. Chemokine up-regulation was detected at early times of stimulation and occurred in a concentration-dependent manner. These data suggest that upon its release into the bloodstream, HZ might interact with resident M
and circulating monocytes and lead to rapid chemokine production. In this context, HZ could stimulate the immunological response at sites of parasite sequestration by inducing potent chemoattractants and activators. However, at higher parasitemias and subsequently higher HZ concentrations, the malarial pigment might also contribute to an exacerbated proinflammatory response (e.g., leukocytosis and high ROS production), causing tissue damage and microvascular flow disturbance.
Our results, demonstrating the capacity of sHZ to trigger M
oxidative stress, are in line with previous studies reporting the same phenomenon after M
treatment with Pf HZ (32) or sHZ (33). However, these studies associated HZ-inducible ROS with depression of M
functions. Human monocyte-derived M
fed with Pf HZ displayed a long-lasting oxidative burst, but were unable to repeat the phagocyte cycle. Moreover, their ability to generate oxidative stress in response to PMA was irreversibly suppressed (32). Similarly, the ability of sHZ to reduce LPS-mediated cytokine and NO production in M
was attributed to sHZ-inducible oxidative stress (33). In contrast, we found that ROS appear to be one of the mechanisms through which the malarial pigment leads to M
chemokine induction. These inconsistencies probably stem from the fact that, as discussed by others (33) and by us (9), the effects of HZ most likely depend on cell susceptibility to oxidative stress, which can vary according to the cell type as well as its tissue source. Whereas HZ was shown to exert a down-regulating effect on NO production by peritoneal M
, it did not modulate this activity in microglial cells (33), and it was able to increase it in bone marrow-derived M
(9). In this context, it is conceivable that rather than a unique effect, HZ might lead to a localized negative or positive ROS-mediated regulation of M
function depending on their antioxidant defenses.
In addition to its capacity to activate ROS, sHZ caused a marked reduction of M
PTP activity. Moreover, in the presence of SOD, an enzyme involved in O ![]()
![]()
![]()
phosphatase activity (40) and increased chemokine mRNA levels in B10R M
(our unpublished observations). Moreover, we demonstrated that PTP inhibition strongly up-regulated the in vivo expression of various chemokine transcripts and enhanced their production in response to infection (41). In parallel, we detected a greater chemokine induction in M
deficient in Src homology region 2 domain-containing phosphatase-1, one of the major M
PTPs (42), compared with wild-type M
(our unpublished observations). In light of these findings, it seems plausible to propose ROS-mediated PTP inactivation as a possible mechanism for HZ-inducible M
chemokine modulation. Even though the M
PTP(s) targeted by sHZ remains to be identified, a general explanation that could account for our results is that upon HZ stimulation, the intracellular equilibrium, in which basal PTP activity predominates over that of PTK, would be altered toward a higher PTK activity due to an increase in ROS and subsequent reduction of PTP activity via their redox-sensitive residues.
Current data provide evidence that a mild oxidative stress can act as a second messenger leading to redox-responsive transcription factor activation and subsequent chemokine gene expression (22, 43). In agreement with these studies, we found that chemokine modulation in response to sHZ required nuclear translocation and binding of the redox-sensitive NF-
B to murine chemokine promoters. Importantly, blockage of oxidative stress with SOD significantly reduced NF-
B translocation, indicating a key role for O ![]()
B activity in response to specific PTP inhibitors, and others reported that SOD pretreatment abrogated M
I
B
tyrosine phosphorylation (45) and NF-
B activation (46) by silica with or without pervanadate. Therefore, it can be envisaged that NF-
B induction by sHZ involves O ![]()
B via tyrosine phosphorylation of I
B
(47), which is mediated by the PTK c-Src (48) and is dependent on the PTK Syk in response to H2O2 (49). Even though ROS do not phosphorylate I
B
on its serine residues, they induce I
B kinase (IKK) activation as well as p65 serine phosphorylation and nuclear translocation (49). Moreover, it was recently reported that SOD treatment reversed increased O ![]()
, IKK
, and the p65 NF-
B subunit (50). Thus, according to this evidence and the knowledge that IKKs phosphorylate p65 (51), it is plausible that IKK activation is required for sHZ-inducible p65 nuclear translocation.
Blockage of ROS with SOD markedly down-regulated NF-
B nuclear translocation in response to the malarial pigment, but did not abolish it, suggesting that ROS-independent mechanisms are also involved. Analysis of possible alternative second messengers revealed that sHZ leads to rapid phosphorylation of ERK1/2 MAPK. Because this event was not affected by SOD administration (data not shown), these data indicate that ERK1/2 activation is not dependent on O ![]()
B activation (52, 53, 54) and chemokine modulation (22, 27), sHZ-inducible I
B
serine phosphorylation, NF-
B nuclear translocation, as well as chemokine up-regulation were impaired in the presence of specific inhibitors of the ERK1/2 pathway. These results are perfectly in line with our published data showing that the up-regulating effect of sHZ on IFN-
-mediated NO production occurred via ERK1/2-dependent NF-
B binding to the murine inducible NO synthase promoter (9). Thus, it is likely that through activation of the same second messengers, HZ modulates different M
functions, including chemokine expression and amplification of M
responses to IFN-
(e.g., NO), which, in turn, would contribute to exacerbate the proinflammatory response during malaria infection.
In conclusion, our findings indicate that HZ-mediated chemokine regulation in M
requires the participation of ROS- and ERK1/2-dependent mechanisms, which appear to elicit independent signals leading to PTP down-regulation, NF-
B nuclear translocation, promoter binding, and subsequent chemokine transcriptional activation. A more detailed characterization of the various signaling pathways involved will help in understanding M
chemokine modulation in response to HZ. Given the importance of establishing the correlation between the clinical manifestations of malaria and the effects of HZ on M
functions, our work may contribute to better define the role of HZ in malaria pathogenesis and might be useful in the development of specific therapeutic targets to tame proinflammatory mediator overproduction.
| Acknowledgments |
|---|
-hematin synthesis and heme quantitation; and Karen Vandal (Université Laval, Québec, Canada) for the experimental procedure to measure oxidative stress generation. | Footnotes |
|---|
1 This work was supported by grants from the Canadian Institutes in Health Research (CIHR; to M.O.). M.O. is member of a CIHR Group in Host-Pathogen Interactions, a recipient of a CIHR Investigator Award, and a Burroughs Wellcome Fund Awardee in Molecular Parasitology. M.J. is a recipient of a Ministère de lÉducation du Québec Ph.D. studentship. M.G. is a recipient of a Fonds pour la Formation de Chercheurs et lAide à la Recherche M.Sc. studentship. ![]()
2 Address correspondence and reprint requests to Dr. Martin Olivier, Department of Microbiology and Immunology, McGill University, 3775 University Street, Duff Medical Building (Room 600), Montréal, Québec, Canada H3A 2B4. E-mail address: martin.olivier{at}staff.mcgill.ca ![]()
3 Abbreviations used in this paper: Pf, Plasmodium falciparum; HZ, hemozoin; IKK, I
B kinase; M
, macrophage; N
, neutrophil; PTK, protein-tyrosine kinase; PTP, protein-tyrosine phosphatase; O ![]()
-hematin; SOD, superoxide dismutase. ![]()
Received for publication February 6, 2004. Accepted for publication October 22, 2004.
| References |
|---|
|
|
|---|
and IL-8 in patients suffering from acute Plasmodium falciparum malaria. Clin. Immunol. Immunopathol. 76:32.[Medline]
chemokine expression. J. Immunol. 170:2759.
-inducible macrophage nitric oxide generation through ERK- and NF-
B-dependent pathways. J. Immunol. 171:4243.
and IL-1
. Am. J. Trop. Med. Hyg. 51:430.
, and MIP-1
) in vitro, and altered thermoregulation in vivo. J. Inflamm. 45:85.[Medline]
-hematin. Nature 404:307.[Medline]
-hematin) mediates the inhibition of nitric oxide and TNF-
production by LPS-stimulated macrophages. Exp. Parasitol. 81:501.[Medline]
B, AP-1, and cAMP response element binding protein. J. Immunol. 169:7026.
, and MIP-1
, members of the chemokine superfamily of proinflammatory cytokines. J. Immunol. 150:4996.[Abstract]
-triggered JAK2 activation. Eur. J. Immunol. 29:3737.[Medline]
B in the immune system. Annu. Rev. Immunol. 12:141.[Medline]
B
phosphorylation and endothelial cell adhesion molecule expression show antiinflammatory effects in vivo. J. Biol. Chem. 272:21096.
-induced macrophage activation by phosphotyrosine phosphatase inhibition: effect on murine Leishmaniasis progression. J. Biol. Chem. 273:13944.
B-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. J. Biol. Chem. 272:12968.
B activation through tyrosine phosphorylation of I
B
in RAW264.7 macrophages. Toxicol. Appl. Pharmacol. 169:59.[Medline]
B activation and protein tyrosine phosphorylation by a tyrosine phosphatase inhibitor, pervanadate, involves reactive oxygen species in silica-stimulated macrophages. Toxicology 151:81.[Medline]
B activation. Proc. Natl. Acad. Sci. USA 96:429.
B
activates NF-
B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. J. Biol. Chem. 278:2072.
B through tyrosine phosphorylation of I
B
and serine phosphorylation of p65: evidence for the involvement of I
B
kinase and Syk protein-tyrosine kinase. J. Biol. Chem. 278:24233.
B in endothelial cells via oxidative stress. Circ. Res. 94:28.
B kinases phosphorylate NF-
B p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353.
B signal pathways. Clin. Cancer Res. 7:435.
enhances cardiac myocyte NO production through MAPK-mediated NF-
B activation. Am. J. Physiol. 277:H1641.[Medline]
B pathway mediates PMA-induced megakaryocytic differentiation of K562 cells. J. Biol. Chem. 276:13186.This article has been cited by other articles:
![]() |
J. W. Griffith, T. Sun, M. T. McIntosh, and R. Bucala Pure Hemozoin Is Inflammatory In Vivo and Activates the NALP3 Inflammasome via Release of Uric Acid J. Immunol., October 15, 2009; 183(8): 5208 - 5220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. M. Fernandes, L. J. de Moura Carvalho, G. M. Zanini, A. M. R. da Silva Ventura, J. M. Souza, P. M. Cotias, I. L. Silva-Filho, and C. T. Daniel-Ribeiro Similar Cytokine Responses and Degrees of Anemia in Patients with Plasmodium falciparum and Plasmodium vivax Infections in the Brazilian Amazon Region Clin. Vaccine Immunol., April 1, 2008; 15(4): 650 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Miu, A. J. Mitchell, M. Muller, S. L. Carter, P. M. Manders, J. A. McQuillan, B. M. Saunders, H. J. Ball, B. Lu, I. L. Campbell, et al. Chemokine Gene Expression during Fatal Murine Cerebral Malaria and Protection Due to CXCR3 Deficiency J. Immunol., January 15, 2008; 180(2): 1217 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Gomez, S. Li, M. L. Tremblay, and M. Olivier NRAMP-1 Expression Modulates Protein-tyrosine Phosphatase Activity in Macrophages: IMPACT ON HOST CELL SIGNALING AND FUNCTIONS J. Biol. Chem., December 14, 2007; 282(50): 36190 - 36198. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Akman-Anderson, M. Olivier, and S. Luckhart Induction of Nitric Oxide Synthase and Activation of Signaling Proteins in Anopheles Mosquitoes by the Malaria Pigment, Hemozoin Infect. Immun., August 1, 2007; 75(8): 4012 - 4019. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gaudreault, S. Fiola, M. Olivier, and J. Gosselin Epstein-Barr Virus Induces MCP-1 Secretion by Human Monocytes via TLR2 J. Virol., August 1, 2007; 81(15): 8016 - 8024. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Parroche, F. N. Lauw, N. Goutagny, E. Latz, B. G. Monks, A. Visintin, K. A. Halmen, M. Lamphier, M. Olivier, D. C. Bartholomeu, et al. From the Cover: Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 PNAS, February 6, 2007; 104(6): 1919 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Coban, K. J. Ishii, S. Uematsu, N. Arisue, S. Sato, M. Yamamoto, T. Kawai, O. Takeuchi, H. Hisaeda, T. Horii, et al. Pathological role of Toll-like receptor signaling in cerebral malaria Int. Immunol., January 1, 2007; 19(1): 67 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Forget, D. J. Gregory, and M. Olivier Proteasome-mediated Degradation of STAT1{alpha} following Infection of Macrophages with Leishmania donovani J. Biol. Chem., August 26, 2005; 280(34): 30542 - 30549. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuwata, T. Nonaka, M. Murakami, and I. Kudo Search of Factors That Intermediate Cytokine-induced Group IIA Phospholipase A2 Expression through the Cytosolic Phospholipase A2- and 12/15-Lipoxygenase-dependent Pathway J. Biol. Chem., July 8, 2005; 280(27): 25830 - 25839. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |